Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,488,966
-
Shares change
-
+685,880
-
Total reported value, excl. options
-
$4,481,066
-
Value change
-
+$2,064,567
-
Number of buys
-
12
-
Number of sells
-
-6
-
Price
-
$3.01
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2022
21 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q4 2022.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,488,966 shares
of 52,664,292 outstanding shares and own 2.8% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (690,000 shares), VANGUARD GROUP INC (269,919 shares), BlackRock Inc. (152,080 shares), AlphaCentric Advisors LLC (100,000 shares), DIMENSIONAL FUND ADVISORS LP (92,455 shares), GEODE CAPITAL MANAGEMENT, LLC (52,922 shares), MORGAN STANLEY (36,338 shares), STATE STREET CORP (26,070 shares), RENAISSANCE TECHNOLOGIES LLC (17,995 shares), and Bank of New York Mellon Corp (15,542 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.